Efficacy and safety of pentavalent rotavirus vaccine in Japan

References

• Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200:Suppl 1 S9 - 15; http://dx.doi.org/10.1086/605025; PMID: 19817620
   PubMed Web of Science ®Google Scholar
• Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar UD, WHO-coordinated Global Rotavirus Surveillance Network. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136 - 41; http://dx.doi.org/10.1016/S1473-3099(11)70253-5; PMID: 22030330
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al, Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23 - 33; http://dx.doi.org/10.1056/NEJMoa052664; PMID: 16394299
   PubMed Web of Science ®Google Scholar
• Bégué RE, Perrin K. Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice. Pediatrics 2010; 126:e40 - 5; http://dx.doi.org/10.1542/peds.2009-2069; PMID: 20587671
   PubMed Web of Science ®Google Scholar
• Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010; 201:1617 - 24; http://dx.doi.org/10.1086/652403; PMID: 20402596
   PubMed Web of Science ®Google Scholar
• Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics 2010; 125:e208 - 13; http://dx.doi.org/10.1542/peds.2009-1246; PMID: 20100757
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Reduction in rotavirus after vaccine introduction--United States, 2000-2009. MMWR Morb Mortal Wkly Rep 2009; 58:1146 - 9; PMID: 19847149
   PubMedGoogle Scholar
• Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010; 125:e199 - 207; http://dx.doi.org/10.1542/peds.2009-1021; PMID: 20083525
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Delayed onset and diminished magnitude of rotavirus activity--United States, November 2007-May 2008. MMWR Morb Mortal Wkly Rep 2008; 57:697 - 700; PMID: 18583958
   PubMedGoogle Scholar
• Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011; 30:Suppl S30 - 4; http://dx.doi.org/10.1097/INF.0b013e3181ffe3eb; PMID: 21183838
   PubMed Web of Science ®Google Scholar
• Parashar UD, Alexander JP, Glass RI, Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:RR-12 1 - 13; PMID: 16902398
   PubMedGoogle Scholar
• Field EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010; 126:e506 - 12; http://dx.doi.org/10.1542/peds.2010-0443; PMID: 20732946
   PubMed Web of Science ®Google Scholar
• Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, et al. Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s National Childhood vaccine schedule. Pediatr Infect Dis J 2011; 30:Suppl S25 - 9; http://dx.doi.org/10.1097/INF.0b013e3181fefdee; PMID: 21183837
   PubMed Web of Science ®Google Scholar
• Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615 - 23; http://dx.doi.org/10.1016/S0140-6736(10)60755-6; PMID: 20692031
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606 - 14; http://dx.doi.org/10.1016/S0140-6736(10)60889-6; PMID: 20692030
   PubMed Web of Science ®Google Scholar
• Kamiya H, Nakano T, Inoue M, Kamiya H, Abd TT, Patel M, et al. A retrospective evaluation of hospitalizations for acute gastroenteritis at 2 sentinel hospitals in central Japan to estimate the health burden of rotavirus. J Infect Dis 2009; 200:Suppl 1 S140 - 6; http://dx.doi.org/10.1086/605028; PMID: 19817592
   PubMedGoogle Scholar
• Nakagomi T, Nakagomi O, Takahashi Y, Enoki M, Suzuki T, Kilgore PE. Incidence and burden of rotavirus gastroenteritis in Japan, as estimated from a prospective sentinel hospital study. J Infect Dis 2005; 192:Suppl 1 S106 - 10; http://dx.doi.org/10.1086/431503; PMID: 16088792
   PubMedGoogle Scholar
• Yokoo M, Arisawa K, Nakagomi O. Estimation of annual incidence, age-specific incidence rate, and cumulative risk of rotavirus gastroenteritis among children in Japan. Jpn J Infect Dis 2004; 57:166 - 71; PMID: 15329449
   PubMed Web of Science ®Google Scholar
• Sato T, Nakagomi T, Nakagomi O. Cost-effectiveness analysis of a universal rotavirus immunization program in Japan. Jpn J Infect Dis 2011; 64:277 - 83; PMID: 21788701
   PubMed Web of Science ®Google Scholar
• RotaTeq™, oral solution. Summary of product characteristics. EMEA/H/C/0669/IB/042. 16-Feb-2013. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000669/WC500054181.pdf. Accessed April 19, 2013.
   Google Scholar
• Vesikari T, Van Damme P, Giaquinto C, Gray J, Mrukowicz J, Dagan R, et al. European society for paediatric infectious diseases/European society for paediatric gastroenterology, hepatology, and nutrition evidence-based recommendations for rotavirus vaccination in Europe. J Pediatr Gastroenterol Nutr 2008; 46:Suppl 2 S38 - 48; http://dx.doi.org/10.1097/MPG.0b013e31816f7a10; PMID: 18460971
   PubMedGoogle Scholar
• Kamiya H, Nakano T, Kamiya H, Yui A, Taniguchi K, Parashar U, Rotavirus Epidemiology Study Group. Rotavirus-associated acute gastroenteritis hospitalizations among Japanese children aged <5 years: active rotavirus surveillance in Mie Prefecture, Japan. Jpn J Infect Dis 2011; 64:482 - 7; PMID: 22116326
   PubMed Web of Science ®Google Scholar
• Duffy LC, Byers TE, Riepenhoff-Talty M, La Scolea LJ, Zielezny M, Ogra PL. The effects of infant feeding on rotavirus-induced gastroenteritis: a prospective study. Am J Public Health 1986; 76:259 - 63; http://dx.doi.org/10.2105/AJPH.76.3.259; PMID: 3004238
   PubMed Web of Science ®Google Scholar
• Mast TC, Cai B, Heaton P, Staus WL. Development and validation of an acute gastroenteritis report card and scoring system to measure the clinical severity of acute gastroenteritis in infants. 22nd Annual Meeting of the European Society for Paediatric Infectious Diseases; 2004 May 26–28. Tampere, Finland. Abstract 155. Available at: http://meetings.espid.org/espid2004/program/session1.asp?SessionId=P07&SSessionDate=5/27/2004. Accessed March 17, 2013.
   Google Scholar